Marinus Pharma (MRNS) – Corporate News
-
Marinus Pharma (MRNS) phase 3 RAISE trial did not meet pre-defined stopping criteria at the interim analysis
-
Marinus Pharma (MRNS) Comments on Patent Challenge by Ovid, Provides Update on Marinus’ Post Grant Review
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to MRNS Stock Lookup